We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01319864
Recruitment Status : Active, not recruiting
First Posted : March 22, 2011
Last Update Posted : October 19, 2016
Children's Healthcare of Atlanta
Pediatric Oncology Experimental Therapeutics Investigation Consortium
Information provided by (Responsible Party):
Todd Cooper, Seattle Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : July 2017